Although dyslipidemia contributes to acquired insulin resistance 30, dyslipidemia did not increase the risk of diabetes in CAS patients, which may be due to the more important role of the reciprocal relationships between impaired insulin-stimulated blood flow and glucose uptake 5 than dyslipidemia in CAS. This evidence concerns the gene INS and metabolic syndrome.